{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:36:48Z","timestamp":1792589808157,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Following immigration to the US, many Africans transition from a low-normal to a high-normal or overweight body mass index (BMI). This weight change is associated with a high rate of prediabetes in the nonobese. Studies in East Asians reveal that glycated albumin is effective in identifying prediabetes in nonobese Asians. Whether this is true in African immigrants is unknown. Therefore, we evaluated the ability of hemoglobin A1c (Hb A1c) and glycated albumin to detect prediabetes in nonobese (BMI &amp;lt;30 kg\/m2) and obese (BMI \u226530 kg\/m2) African immigrants.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Oral glucose tolerance tests (OGTTs) were performed in 236 self-identified healthy African immigrants [mean (SD) BMI 27.6 (4.4) kg\/m2]. Prediabetes diagnosis was based on glucose criteria for the OGTT. Diagnostic sensitivity of Hb A1c and glycated albumin was determined by thresholds at the upper quartile for each [Hb A1c \u22655.7% (39 mmol\/mol), glycated albumin \u226513.77%].<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Based on glucose criteria for the OGTT, prediabetes was detected in 36% (85\/236). BMI and Hb A1c were positively correlated (r = 0.22, P &amp;lt; 0.001), whereas BMI and glycated albumin were negatively correlated (r = \u22120.24, P &amp;lt; 0.001). Although the sensitivities of Hb A1c and glycated albumin were similar in nonobese immigrants (37% vs 42%, P = 0.75), prediabetes was detected in 21 nonobese Africans by glycated albumin alone, in 18 by Hb A1c alone, and in 4 by both tests. Therefore, sensitivity of the combined tests was better than for Hb A1c alone(72% vs 37%, P &amp;lt; 0.01). In the obese, Hb A1c was a much better diagnostic test than glycated albumin (64% vs 16%, P &amp;lt; 0.01) and combining the tests did not improve sensitivity (72% vs 64%, P = 0.50).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Glycated albumin contributes by identifying prediabetes not detected by Hb A1c in nonobese African immigrants. ClinicalTrials.gov Identifier: NCT00001853<\/jats:p><\/jats:sec>","DOI":"10.1373\/clinchem.2016.261255","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T02:38:55Z","timestamp":1473820735000},"page":"1524-1532","source":"Crossref","is-referenced-by-count":36,"title":["Glycated Albumin Identifies Prediabetes Not Detected by Hemoglobin A1c: The Africans in America Study"],"prefix":"10.1093","volume":"62","author":[{"given":"Anne E","family":"Sumner","sequence":"first","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle T","family":"Duong","sequence":"first","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna A","family":"Bingham","sequence":"first","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola C","family":"Aldana","sequence":"first","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madia","family":"Ricks","sequence":"first","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian S","family":"Mabundo","sequence":"first","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall K","family":"Tulloch-Reid","sequence":"first","affiliation":[{"name":"Tropical Medicine Research Institute, University of the West Indies, Kingston, Jamaica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie T","family":"Chung","sequence":"first","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B","family":"Sacks","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"2020022605355222600_B1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 7th ed. 2015. www.IDF.org\/diabetesatlas. (Accessed May 2016)."},{"key":"2020022605355222600_B2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"2020022605355222600_B3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2020022605355222600_B4","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","article-title":"Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study","volume":"368","author":"Lindstrom","year":"2006","journal-title":"Lancet"},{"key":"2020022605355222600_B5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.7326\/0003-4819-159-8-201310150-00007","article-title":"Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis","volume":"159","author":"Schellenberg","year":"2013","journal-title":"Ann Intern Med"},{"key":"2020022605355222600_B6","first-page":"1039","article-title":"National Diabetes Data Group","volume":"28","author":"Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance","year":"1979","journal-title":"Diabetes"},{"key":"2020022605355222600_B7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/dc10-1546","article-title":"A1C vs glucose testing: a comparison","volume":"34","author":"Sacks","year":"2011","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.atherosclerosis.2015.07.037","article-title":"A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan","volume":"242","author":"Hsu","year":"2015","journal-title":"Atherosclerosis"},{"key":"2020022605355222600_B9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.metabol.2015.03.003","article-title":"Glycated albumin as a diagnostic tool for diabetes in a general Japanese population","volume":"64","author":"Ikezaki","year":"2015","journal-title":"Metabolism"},{"key":"2020022605355222600_B10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2337\/dc15-1360","article-title":"Racial differences in and prognostic value of biomarkers of hyperglycemia","volume":"39","author":"Parrinello","year":"2016","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0168-8227(89)90011-9","article-title":"The relative value of glycated albumin, hemoglobin A1c and fructosamine when screening for diabetes mellitus","volume":"7","author":"Shima","year":"1989","journal-title":"Diabetes Res Clin Pract"},{"key":"2020022605355222600_B12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2337\/dc15-1699","article-title":"A1C combined with glycated albumin improves detection of prediabetes in Africans: the Africans in America Study","volume":"39","author":"Sumner","year":"2016","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B13","doi-asserted-by":"crossref","first-page":"e0146780","DOI":"10.1371\/journal.pone.0146780","article-title":"Serum glycated albumin to guide the diagnosis of diabetes mellitus","volume":"11","author":"Wu","year":"2016","journal-title":"PloS One"},{"key":"2020022605355222600_B14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2337\/dc10-S003","article-title":"Summary of revisions for the 2010 Clinical Practice Recommendations","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/dc09-1524","article-title":"Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988\u20132006","volume":"33","author":"Cowie","year":"2010","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B16","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.2337\/dc10-0679","article-title":"A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"33","author":"Lorenzo","year":"2010","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2337\/dc14-1179","article-title":"Detection of abnormal glucose tolerance in Africans is improved by combining a1c with fasting glucose: the Africans in America Study","volume":"38","author":"Sumner","year":"2015","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/jc.2011-1894","article-title":"Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes","volume":"97","author":"Herman","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022605355222600_B19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2337\/dc15-2727","article-title":"Role of glycated proteins in the diagnosis and management of diabetes: research gaps and future directions","volume":"39","author":"Welsh","year":"2016","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B20","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/srep01671","article-title":"The distribution of haemoglobin C and its prevalence in newborns in Africa","volume":"3","author":"Piel","year":"2013","journal-title":"Sci Rep"},{"key":"2020022605355222600_B21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"2020022605355222600_B22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1932296814567227","article-title":"Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes","volume":"9","author":"Danese","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"2020022605355222600_B23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/pedi.12258","article-title":"Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia\u20131,5-anhydroglucitol, fructosamine, and glycated albumin","volume":"17","author":"Chan","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"2020022605355222600_B24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1507\/endocrj.K05-137","article-title":"Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients","volume":"53","author":"Koga","year":"2006","journal-title":"Endocr J"},{"key":"2020022605355222600_B25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2006.10.013","article-title":"Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels","volume":"378","author":"Koga","year":"2007","journal-title":"Clin Chim Acta"},{"key":"2020022605355222600_B26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.diabres.2005.07.008","article-title":"Glycated albumin is low in obese, non-diabetic children","volume":"71","author":"Nishimura","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"2020022605355222600_B27","doi-asserted-by":"crossref","first-page":"e51098","DOI":"10.1371\/journal.pone.0051098","article-title":"Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"key":"2020022605355222600_B28","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/dc15-2338","article-title":"Variations in diabetes prevalence in low-, middle-, and high-income countries: Results from the Prospective Urban and Rural Epidemiology Study","volume":"39","author":"Dagenais","year":"2016","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B29","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/dc11-1055","article-title":"Metabolic syndrome does not detect metabolic risk in African men living in the U.S","volume":"34","author":"Ukegbu","year":"2011","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/met.2014.0026","article-title":"Worse cardiometabolic health in African immigrant men than African American men: reconsideration of the healthy immigrant effect","volume":"12","author":"O'Connor","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"2020022605355222600_B31","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc16-S005","article-title":"Classification and Diagnosis of Diabetes","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B32","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","article-title":"Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels","volume":"32","author":"Utzschneider","year":"2009","journal-title":"Diabetes Care"},{"key":"2020022605355222600_B34","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/01.ASN.0000068462.38661.89","article-title":"The effects of weight loss on renal function in patients with severe obesity","volume":"14","author":"Chagnac","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2020022605355222600_B35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA"},{"key":"2020022605355222600_B36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants","volume":"377","author":"Finucane","year":"2011","journal-title":"Lancet"},{"key":"2020022605355222600_B37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2796.2012.02513.x","article-title":"Current controversies in the use of haemoglobin A1c","volume":"271","author":"Hare","year":"2012","journal-title":"J Intern Med"},{"key":"2020022605355222600_B38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2009.01.013","article-title":"Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects","volume":"84","author":"Koga","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"2020022605355222600_B39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4158\/EP.14.7.933","article-title":"Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists","volume":"14","author":"Garber","year":"2008","journal-title":"Endocr Pract"},{"key":"2020022605355222600_B40","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2337\/dc14-2459","article-title":"Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)","volume":"38","author":"Herman","year":"2015","journal-title":"Diabetes Care"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/62\/11\/1524\/32645216\/clinchem1524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/62\/11\/1524\/32645216\/clinchem1524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:01:45Z","timestamp":1657278105000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/62\/11\/1524\/5611973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,1]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2016.261255","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,11,1]]},"published":{"date-parts":[[2016,11,1]]}}}